Amedisys (AMED +6.3%) reported Q2 revenue of $485M (-1.6% Y/Y)
Home health segment: medicare revenue equaled $192.2M, while non-medicare revenue of $97.3M
Hospice segment: medicare revenue equaled $167M, while non-medicare revenue of $10.1M
Personal Care segment: non-medicare revenue of $17.7M
Adjusted EBITDA of $66.4M vs. $61.4M last year.
Adjusted EPS of $1.34 vs. $1.21 last year
Gross margin of 121.3M.
2020 Guidance: Revenue $2.04B-2.07B, Adjusted EBITDA $245M-255M, Adjusted EPS $4.84-5.06.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.